Dr. Xenophon (Xenios) Papademetris is a professor of Radiology & Biomedical Imaging, and Biomedical Engineering at Yale. His research interests are in the areas of medical image analysis and the design and implementation of software for medical applications. In addition to co-authoring the textbook "Introduction to Medical Software: Foundations for Digital Health, Devices, and Diagnostics", he was also the lead instructor for the companion Coursera Class "Introduction to Medical Software."
Some related articles on medical software can be found at: https://www.xpapademetris.com/medical-software-articles
AYESHA N. QURAISHI
Dr. Ayesha Quraishi teaches Creating Healthcare and Life Sciences Ventures at the Yale University School of Management as well as co-instructor for Healthcare Ventures at the Massachusetts Institute of Technology. She is a practicing surgeon and serves as the Chief of the Division of Otolaryngology at the Cambridge Health Alliance, a teaching affiliate of Harvard Medical School. Previously she served as the Clinical Director of the Yale School of Medicine Center of Biomedical Innovation and Technology and mentored several early stage startups at the Yale School of Medicine. She helped launch a digital health startup, Doctella, a patient engagement platform that was acquired and she serves has served as a consultant to Lambay Advisors on a variety of health IT projects. Ayesha has an undergraduate degree from McGill University, a medical doctorate from Penn State University and an MBA from the Massachusetts Institute of Technology Sloan School of Management. She has served on multiple medical and advisory Boards and currently the American Academy of Otolaryngic Allergy (AAOA).
For more information see her LinkedIn profile.
GREGORY P. LICHOLAI
Dr. Licholai teaches Sustainable Innovation in Healthcare at Yale University School of Management where he is Co-Director of the Center for Digital Health and teaches Innovating Health Care at Harvard Business School. He is Chief Medical and Information Officer at ICON, a leading pharmaceutical service, healthcare data and contract research provider. Previously, he was President of rare disease at Moderna Therapeutics; President and Chief Medical Officer at Castle Creek Pharmaceuticals and was a partner at McKinsey & Co. where he ran the healthcare data service line. He was also a senior executive at Proteostasis, Amicus Therapeutics and Medtronic Neurological as well as venture investor for Domain Associates. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University and Boston College. He trained in Neurological Surgery at the Brigham and Women's, Children's, and Massachusetts General Hospitals of Harvard Medical School. He serves on multiple company and non-profit boards including advisor to the Clinical Trials Transformation Initiative (CTTI), a public private partnership co-founded by Duke University and the Food and Drug Administration (FDA). He writes about innovation in healthcare for Forbes.
For more information see his LinkedIn profile.